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Sir,
We read with great interest the article by Frost (2013) on mesothelioma
latency among British asbestos workers. The author examined data from the
GB Asbestos Survey, a large prospective cohort established in 1971 to
monitor the long-term health of asbestos workers. On the basis of analyses of
latency (defined as the time from first occupational exposure to asbestos
to death from mesothelioma) among mesothelioma deaths in the period
1978–2005, the author concluded that the study did not find sufficient
evidence of an inverse relationship between the intensity of asbestos exposure
and the length of the latency period. However, there are methodological
problems that undermine these results. Even if the whole cohort of 94 960
subjects was available, only mesothelioma deaths (614 subjects) were
included in the analysis (Frost, 2013). It is well known that comparing
survival times only among cases is a flawed approach (Pike and Doll, 1965;
Langholz et al, 1999; Consonni, 2013). In a cohort study, only a proportion of
subjects develops the outcome of interest. The remaining subjects will be still
alive at the end of the study or die due to a different cause of death. For these
individuals, the survival times for the outcome of interest will not be
observable. This phenomenon is known as ‘censoring’ in survival analysis
(Cleves et al, 2010). In this situation, it could seem attractive to use only the
available survival times from the cases to calculate mean (or median) survival
time in the different groups (e.g., subjects exposed and not exposed to a risk
factor) and compare them. The problem with this approach is that survival
times of cases are not representatives of survival times of the whole cohort.
This can be showed with a simple example. Let’s imagine to conduct a
clinical study over 40 subjects: 20 treated with a new drug and 20 treated with
placebo. Note that in this example ‘survival’ is precisely a ‘latency’ (time since
first exposure to the drug). Let us assume that all the subjects are followed
until death occurs and that survival times of the subjects in the experimental
group were 3, 4, 6, 6, 8, 9, 10, 13, 17, 28, 39, 41, 47, 49, 65, 68, 80, 96, 123, 140
months, and those in the placebo group were 1, 3, 3, 5, 6, 7, 11, 12, 13, 14, 16,
18, 22, 23, 25, 31, 31, 38, 92, 114 months. Because the survival times of all the
subjects were observed, it would be possible to calculate mean and median
survival times in the two groups (means: 43 and 24 months; medians: 33 and
15 months, respectively). However, in most epidemiological studies it is not
possible to follow the subjects until they all die. Let us assume now that the
study ends for practical reasons 48 months after the allocation of the
treatment. Survival times larger than 48 months will then become
unobservable. The survival times in the two groups available to the
researchers would now be 3, 4, 6, 6, 8, 9, 10, 13, 17, 28, 39, 41, 47 months
in the experimental group and 1, 3, 3, 5, 6, 7, 11, 12, 13, 14, 16, 18, 22, 23, 25,
31, 31, 38 months in the placebo group. The mean and median survival time
in the two groups would appear now to be 18 and 16 months (means) and 10
and 13 months (medians), respectively, very different from the situation in
which all survival times are observed and suggesting only a slight increase of
survival in the experimental group compared with the placebo group.
Therefore, if we used the approach adopted by Frost (2013) in her paper and
calculate mean (or median) survival using only the available survival times
from cases, we would obtain a different, incorrect result. Note that this
phenomenon is quite general and goes beyond the fictitious example above.
It happens because censoring ‘cuts’ the right tail of the distributions of the
survival times in the two groups, making look the distributions more similar
than they really are. It is noteworthy that even using a regression model like
the one adopted by Frost (2013) will not solve the problem. Conversely,
including all the subjects in the analysis and taking into account censoring
trough standard techniques for survival analysis would produce unbiased
results (Cleves et al, 2010). Analyses on the basis of data only from cases are
particularly prone to bias when the proportion of censored survival times is
high. Unfortunately this is the case of the study by Frost (2013), where more
than 99% of the survival times for mesothelioma were not directly
observable. This casts serious doubts on the validity of the study.
The mistake of restricting the analysis on cases without considering the
population from which cases originated was recognised almost 50 years ago
by Pike and Doll (1965). Despite that paper and the fact that scientific papers
(Langholz et al, 1999), statistical (Colton, 1974) and epidemiological books
(Rothman, 2012; Weiss, 2012) explicitly discourage the analysis of survival
times among cases only, this problem occasionally re-appears in the literature
(Consonni, 2013). Notably, this problem affected also studies based on case
series from mesothelioma registries (Yeung et al, 1999; Neumann et al, 2001;
Marinaccio et al, 2007; Bianchi and Bianchi, 2009).
In summary, the results reported in the paper by Frost (2013) are not
interpretable because they were on the basis of analyses among mesothelioma
deaths only, which are known to be incorrect. The only meaningful way to
address the issue of mesothelioma latency using survival techniques is
to include all subjects, and to treat those who do not die from mesothelioma
during the follow-up period as ‘censored’ (Cleves et al, 2010). This
approach implies the use of information from all the 94 960 workers in the
GB cohort.
After all, occupational epidemiologists do not restrict analyses to dead
workers while studying carcinogens and oncologists do not restrict analyses
to dead patients while analysing cancer survival.
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